Trial Profile
The Effects of Administering Clopidogrel on the Pharmacokinetics of Rosuvastatin in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Atherosclerosis; Hyperlipidaemia; Ischaemic heart disorders; Myocardial infarction; Peripheral arterial occlusive disorders; Stroke; Thrombosis; Unstable angina pectoris
- Focus Pharmacokinetics
- 18 Mar 2013 Planned End Date changed from 1 Dec 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
- 18 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Apr 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.